calcium dobesilate has been researched along with Brain Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angulo, J; Carceller, F; Cuevas, P; Cuevas-Bourdier, A; Giménez-Gallego, G; González-Corrochano, R | 1 |
| Cuevas, P; Díaz-González, D; Dujovny, M; Giménez-Gallego, G | 1 |
| Cuevas, P; Díaz-González, D; Dujovny, M; Giménez-Gallego, G; Lozano, RM; Sánchez, I | 1 |
3 other study(ies) available for calcium dobesilate and Brain Neoplasms
| Article | Year |
|---|---|
Antiglioma effects of a new, low molecular mass, inhibitor of fibroblast growth factor.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Calcium Dobesilate; Cell Line, Tumor; Fibroblast Growth Factors; Glioma; Neoplasms, Experimental; Rats | 2011 |
Dihydroxy-2,5 benzenesulphonate (dobesilate) elicits growth arrest and apoptosis in glioma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Calcium Dobesilate; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Glioma; Inhibitory Concentration 50; Rats | 2005 |
Dobesilate inhibits the activation of signal transducer and activator of transcription 3, and the expression of cyclin D1 and bcl-XL in glioma cells.
Topics: Animals; Apoptosis; bcl-X Protein; Brain Neoplasms; Calcium Dobesilate; Cell Division; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Cyclin D1; Down-Regulation; Fibroblast Growth Factors; Gene Expression Regulation, Neoplastic; Glioma; Growth Inhibitors; Hemostatics; Rats; Signal Transduction; STAT3 Transcription Factor; Transcriptional Activation | 2006 |